APOTEX-Varenicline 0.5 mg varenicline (as tartrate) tablets and 1.0 mg varenicline (as tartrate) tablets composite blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

varenicline tartrate, Quantity: 1.71 mg (Equivalent: varenicline, Qty 1 mg)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

varenicline tartrate

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: microcrystalline cellulose; calcium hydrogen phosphate; hypromellose; triacetin; hyprolose; titanium dioxide; indigo carmine aluminium lake; magnesium stearate

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

11 x 0.5 mg tablets and 42 x 1 mg tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Varenicline tablets are indicated as an aid to smoking cessation in adults over the age of 18 years.

Sommarju tal-prodott:

Visual Identification: Blue, modified capsule-shaped, biconvex, film coated tablet engraved "APO" on one side, "VAR" over"1" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2014-04-03